Symbol="CYCCP"
AssetType="Preferred Stock"
Name="Cyclacel Pharmaceuticals Inc"
Description="Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey."
CIK="1130166"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="31184100"
EBITDA="-28385000"
PERatio="None"
PEGRatio="0"
BookValue="0.809"
DividendPerShare="0"
DividendYield="0.0375"
EPS="-2.047"
RevenuePerShareTTM="0.01"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.576"
ReturnOnEquityTTM="-1.051"
RevenueTTM="150000"
GrossProfitTTM="-455000"
DilutedEPSTTM="-2.047"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="1.078"
num_52WeekHigh="22.12"
num_52WeekLow="5.73"
num_50DayMovingAverage="12.51"
num_200DayMovingAverage="12.33"
SharesOutstanding="12497400"
DividendDate="2023-08-01"
ExDividendDate="2023-07-20"
symbol="CYCCP"
open="17.00"
high="17.00"
low="17.00"
price="17.00"
volume="2057.00"
latest_trading_day="2023-08-03"
previous_close="16.40"
change="0.60"
change_percent="3.6585%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="56"
trend_strength="Strong Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="44"
Volume_recent_avg="2611"
Change_recent_avg="-0.03"
Delta_recent_avg="0.98"
Variance_recent_avg="0.49"
Change_ratio_recent_avg="-0.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="44"
Aroon_momentum_negative="56"
image_negative_thumbnail_id_1="1139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_negative_thumbnail_id_2="514"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="644"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0064.jpeg"
image_positive_thumbnail_id_2="611"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0097.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
